|
ORGS Orgenesis Inc 1460602 |
| Income Statement |
|
Revenue
|
form10-q
|
347,000 |
|
Net Income
|
form10-q
|
-9,120,000 |
|
Profit Margin
|
|
-2628.24% |
| Balance Sheet |
|
Current Assets
|
2,519,000 |
|
Assets
|
29,687,000 |
|
Current Liabilities
|
36,049,000 |
|
Liabilities
|
53,615,000 |
|
Equity
|
-23,928,000 |
|
Shares Out
|
46,926,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-14,978,000 |
|
Investing Cash Flow
|
73,000 |
| Market Analysis |
Market Cap
|
26,608,921 |
|
Price
|
1.39 |
|
BVPS
|
0.84 |
|
PB
|
1.65 |
|
EPS
|
-0.87 |
|
PS
|
19.17 |
|
FCF
|
-14,905,000 |
|
| Earnings |
|
| Apr |
May |
Jun |
| 4/15 |
|
5/20 |
0.29 |
|
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ORGS documents filed with the SEC.
ORGS Filings
Clear
